Literature DB >> 8388791

Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.

G J Malanoski1, G M Eliopoulos, M J Ferraro, R C Moellering.   

Abstract

The in vitro susceptibility of 27 clinical isolates of Helicobacter pylori to erythromycin, clarithromycin, azithromycin and temafloxacin under various pH conditions was evaluated. Clarithromycin (MIC90 0.03 micrograms/ml) was found to be significantly more active than either erythromycin (MIC90 0.125 micrograms/ml) or azithromycin (MIC90 0.25 micrograms/ml) at a neutral pH. Lowering the pH to 5.75 resulted in a loss in efficacy from 8- to 32-fold for all three macrolides studied. The MIC90 of clarithromycin (0.5 micrograms/ml) remained lower than those of azithromycin (2 micrograms/ml) and erythromycin (4 micrograms/ml). No synergism or antagonism was observed with combinations of clarithromycin and temafloxacin at either the neutral or lower pH values.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388791     DOI: 10.1007/bf01967591

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  Clarithromycin and omeprazole for Helicobacter pylori.

Authors:  R P Logan; P A Gummett; B T Hegarty; M M Walker; J H Baron; J J Misiewicz
Journal:  Lancet       Date:  1992-07-25       Impact factor: 79.321

2.  Failure of azythromycin to eradicate Campylobacter pylori from the stomach because of acquired resistance during treatment.

Authors:  Y Glupczynski; A Burette
Journal:  Am J Gastroenterol       Date:  1990-01       Impact factor: 10.864

3.  Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents.

Authors:  M L Grayson; G M Eliopoulos; M J Ferraro; R C Moellering
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

4.  Failure of ciprofloxacin to eradicate Campylobacter pylori from the stomach.

Authors:  J W Stone; R Wise; I A Donovan; J Gearty
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

5.  Spiral organisms in endoscopic biopsies of the human stomach.

Authors:  T P Rollason; J Stone; J M Rhodes
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

6.  The susceptibility of Campylobacter pylori to antiulcer agents and antibiotics.

Authors:  T Nagate; K Numata; K Hanada; I Kondo
Journal:  J Clin Gastroenterol       Date:  1990       Impact factor: 3.062

Review 7.  The role of antibiotics in Campylobacter pylori associated peptic ulcer disease.

Authors:  E Bayerdörffer; R Ottenjann
Journal:  Scand J Gastroenterol Suppl       Date:  1988

8.  Susceptibility of Campylobacter pyloridis to three macrolide antibiotics (erythromycin, roxithromycin [RU 28965], and CP 62,993) and rifampin.

Authors:  S Czinn; H Carr; S Aronoff
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

9.  Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents.

Authors:  D L Shungu; D R Nalin; R H Gilman; H H Gadebusch; A T Cerami; C Gill; B Weissberger
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

10.  Susceptibility of Campylobacter pylori to the newer cephalosporin antibiotics.

Authors:  S J Czinn; H Carr; V Hupertz
Journal:  Chemotherapy       Date:  1989       Impact factor: 2.544

View more
  12 in total

1.  Antimicrobial susceptibilities of Helicobacter pylori isolates under microaerophilic atmospheres established by two different methods.

Authors:  I Kobayashi; H Muraoka; T Saika; M Nishida; T Fujioka; M Nasu
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

2.  Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents.

Authors:  Y J Debets-Ossenkopp; F Namavar; D M MacLaren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

3.  Discrepancies between E-test and agar dilution methods for testing metronidazole susceptibility of Helicobacter pylori.

Authors:  T Alarcón; D Domingo; M López-Brea
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

Review 4.  Helicobacter pylori: the place of the new macrolides in the eradication of the bacteria in peptic ulcer disease.

Authors:  A Burette; Y Glupczynski
Journal:  Infection       Date:  1995       Impact factor: 3.553

Review 5.  A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.

Authors:  A Hackelsberger; P Malfertheiner
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

6.  Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format. The Gastrointestinal Physiology Working Group of Universidad Peruana Cayetano Heredia and the Johns Hopkins University.

Authors:  A Vasquez; Y Valdez; R H Gilman; J J McDonald; T U Westblom; D Berg; H Mayta; V Gutierrez
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

7.  Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands.

Authors:  A A van Zwet; W A de Boer; P M Schneeberger; J Weel; A R Jansz; J C Thijs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

8.  Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes.

Authors:  R C Goldman; D Zakula; R Flamm; J Beyer; J Capobianco
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

9.  Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state.

Authors:  L E Gustavson; J F Kaiser; A L Edmonds; C S Locke; M L DeBartolo; D W Schneck
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

10.  Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents.

Authors:  W H Wang; W M Wong; D Dailidiene; D E Berg; Q Gu; K C Lai; S K Lam; B C Y Wong
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.